BXP, Inc. (BXP)
(Delayed Data from NYSE)
$73.12 USD
+2.25 (3.17%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $73.14 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$73.12 USD
+2.25 (3.17%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $73.14 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Zacks News
Massachusetts-based Boston Properties, Inc. — the real estate investment trust (REIT) — owns and develops Class A office real estates in the United States. The company also owns interest in 13 retail properties, six residential properties and a hotel. Its properties are concentrated in five core markets: Boston, Los Angeles, New York, San Francisco and Washington, DC. These regions comprise traditional tenants, like government, financial services and law firms as well as businesses involving technology, advertising, media, life sciences and medical devices.
Prologis (PLD) Tops Q3 FFO & Revenues Estimates, Revises View
by Zacks Equity Research
Prologis (PLD) reports better-than-anticipated third-quarter 2022 results with the top line growing year over year. However, it revises 2022 guidance due to unfavorable macroeconomic conditions.
Boston Properties' (BXP) Buyout Boosts Life-Science Portfolio
by Zacks Equity Research
Boston Properties (BXP) acquires 125 Broadway in Kendall Square in Cambridge, MA, from Biogen for $592 million. The move aids its expansion efforts in the life sciences space in Cambridge.
Boston Properties (BXP) Disposes of Office Property for $531M
by Zacks Equity Research
As part of its capital-reallocation strategy focused on expansion in the Seattle market, Boston Properties (BXP) sells 601 Massachusetts Avenue, NW, Washington, DC, for $531 million.
Is it Wise to Hold on to Vornado Realty (VNO) Stock Now?
by Zacks Equity Research
Vornado (VNO) is poised to gain from its high-quality assets and an improving U.S. office market. However, stiff competition from developers, owners and operators of office properties is a concern.
Ventas' (VTR) Q2 FFO Meets, Revenues Up Y/Y, SHOP NOI Rises
by Zacks Equity Research
Ventas' (VTR) Q2 results display year-over-year top-line growth aided by solid demand and improving pricing power for the senior housing operating portfolio.
Iron Mountain's (IRM) Q2 FFO Beats, Revenues Rise Y/Y
by Zacks Equity Research
Iron Mountain's (IRM) second-quarter top line rises year over year, driven by solid performance of the storage and service segments, and the data-center business. It reaffirms 2022 guidance.
OUTFRONT Media (OUT) Q2 FFO Beats Estimates, Revenues Up Y/Y
by Zacks Equity Research
OUTFRONT Media (OUT) reports better-than-anticipated second-quarter 2022 results aided by solid top-line growth backed by a rise in billboard revenues.
Rayonier's (RYN) FFO and Revenues Surpass Estimates in Q2
by Zacks Equity Research
Rayonier's (RYN) Q2 performance outpaces estimates driven by solid results in the Southern Timber and Pacific Northwest Timber segments.
Host Hotels (HST) Beats on Q2 FFO & Revenues, Doubles Dividend
by Zacks Equity Research
Host Hotels (HST) reports better-than-anticipated Q2 results driven by a rise in leisure travel and improved group demand in urban markets. It also announces doubling of its quarterly dividend.
Healthpeak's (PEAK) Q2 FFO & Revenues Beat, Same-Store NOI Up
by Zacks Equity Research
Healthpeak's (PEAK) Q2 results outpace estimates driven by solid top-line growth. Same-store net operating income for the total portfolio improves year over year. It reaffirms 2022 FFO guidance.
Extra Space Storage's (EXR) FFO & Revenues Beat, '22 View Up
by Zacks Equity Research
Extra Space Storage's (EXR) second-quarter results outshine estimates. Solid top-line growth was witnessed along with improvement in same-store net operating income. It raises its 2022 guidance.
Vornado's (VNO) FFO and Revenues Surpass Estimates in Q2
by Zacks Equity Research
Vornado (VNO) reports better-than-expected second-quarter 2022 performance driven by solid top-line growth. Also, the same-store net operating income improves across the portfolio.
Simon Property (SPG) Q2 FFO Beats, View Up, Dividend Hiked
by Zacks Equity Research
Simon Property's (SPG) Q2 results reflect healthy operating performance and year-over-year improvement in occupancy levels. This retail REIT also raises its 2022 FFO per share outlook and dividend.
SBA Communications (SBAC) Q2 FFO & Revenues Top, '22 View Up
by Zacks Equity Research
SBA Communications' (SBAC) second-quarter performance outshines estimates. Results were driven by an increase in site-leasing and accretive acquisitions. It raises 2022 outlook.
Cousins Properties (CUZ) Q2 FFO Beats Estimates, Revenues Lag
by Zacks Equity Research
Cousins Properties' (CUZ) second-quarter FFO outpaces expectations. However, the top line lags estimates with leasing activity declining year over year.
Digital Realty's (DLR) Q2 FFO & Revenues Miss Estimates
by Zacks Equity Research
Digital Realty's (DLR) second-quarter FFO per share fails to meet expectations. Although the top line witnessed year-over-year growth, it lags estimates. DLR revises 2022 outlook.
SITE Centers (SITC) Q2 OFFO & Revenues Beat, '22 View Up
by Zacks Equity Research
SITE Centers' (SITC) second-quarter results outshine estimates. The performance was aided by growth in annualized base rent and an increase in property acquisitions. It raises 2022 outlook.
Macerich's (MAC) Q2 FFO Beats, Revenues Miss, Stock Gains
by Zacks Equity Research
Macerich (MAC) witnesses year-over-year growth in occupancy and same-center net operating income. However, the top line lags estimates. It narrows and raises the midpoint of its 2022 FFO guidance.
Kimco's (KIM) Q2 FFO & Revenues Beat Estimates, '22 View Up
by Zacks Equity Research
Kimco's (KIM) second-quarter results outshine estimates, primarily driven by higher occupancy and rental rate growth. It raises 2022 outlook.
Equinix (EQIX) Q2 AFFO Beats Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Equinix (EQIX) reports better-than-anticipated second-quarter results driven by strong demand for its colocation and interconnection services.
AvalonBay Communities (AVB) Q2 FFO & Revenues Beat, View Up
by Zacks Equity Research
AvalonBay's (AVB) second-quarter results outshine estimates, primarily driven by growth in same-store residential rental revenues and average rental rates. It raises 2022 outlook.
Boston Properties (BXP) Beats Q2 FFO Estimates, Ups '22 View
by Zacks Equity Research
Boston Properties (BXP) reports better-than-anticipated second-quarter results with year-over-year improvement in the bottom line. It raises 2022 outlook.
Boston Properties (BXP) Beats Q2 FFO and Revenue Estimates
by Zacks Equity Research
Boston Properties (BXP) delivered FFO and revenue surprises of 4.86% and 0.54%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Key Factors to Impact Boston Properties' (BXP) Q2 Earnings
by Zacks Equity Research
Amid uneven U.S. office market recovery, improving demand for Boston Properties' (BXP) office buildings and life-science assets in key U.S. markets is likely to have driven its Q2 earnings.
Boston Properties (BXP) Buys Madison Centre, Expands in Seattle
by Zacks Equity Research
Boston Properties (BXP) continues to expand in the Seattle market adding Madison Centre to its Class A office portfolio.